Don’t slam baseball over drugs: an MLB investigation is what led to all of this

26 Comments

As has been the case with every single positive PED test involving a notable player over the past several years, I have no doubt that in the coming days we’ll see some variation of the following from a baseball writer:

Baseball wants you to think its drug problems are gone, but they’re not. With this latest story we now know that it’s as if it were 1998 all over again. Everyone is cheating and juicing and if you think that what you’re seeing on the field is genuine, think again.  Don’t let Bud Selig and Michael Weiner tell you that they have faith in the drug testing program. It’s all p.r. and it’s all bunk. We’re still in the Steroid Era.

I embellish, but only a little. We’ve all seen that sort of thing before and I assure you we’ll see it again.

But before you buy into that, go read Michael S. Schmidt’s report of this Miami business in the New York Times.  In addition to the things we already know, Schmidt reports that the reason this all came to light in the first place was because of an MLB investigation into an employee of Melky Cabrera’s agents in the wake of his positive test last year.

The upshot: MLB caught a cheating player with testing. Its investigations arm got involved and sniffed out the baloney in his story.  They dug deeper and made connections to past information they had on PED use but which was unactionable at the time. They brought in law enforcement to assist in the investigation.  The heat from that investigation led to this information coming out, and now they’re pledging to investigate further, with possible discipline to follow.

Some people may look at all of this as evidence of some epidemic and Major League Baseball being asleep at the switch.  I look at it as a pretty damn proactive and robust testing and investigative program doing the job it was set up to do.  Maybe that doesn’t make baseball 100% clean, but nothing in society is.  Heck, not even all sports is.  When was the last time the NFL, NBA or NHL was seen as being on top of things with respect to performance enhancing drugs as Major League Baseball is?  The most famous player in the Super Bowl just got linked to a banned PED today. We’ll hear little of this compared to the A-Rod business over the next week, I assure you.

Yet I expect people will still take their shots at MLB over all of this.  They’re so used to doing it, it’s hard to stop.

 

Report: Rangers to receive Matt Moore from Giants

Getty Images
1 Comment

John Shea of the San Francisco Chronicle reports that the Giants have traded left-hander Matt Moore to the Rangers. The deal is pending a physical and has yet to be confirmed by the clubs. Shea adds that the Rangers are expected to receive several prospects in return.

Moore, 28, was brought over to the Giants in 2016 in a deadline swap for shortstop Matt Duffy and two minor leaguers. He went 6-15 in his first full season with the Giants, producing a 5.52 ERA, 3.5 BB/9 and 7.6 SO/9 through 32 starts and 174 1/3 innings in 2017. Moore stands to earn $9 million in 2018 and has a $10 million club option (and $1 million buyout) on his contract in 2019.

According to both Shea and Henry Schulman, the move is part of the Giants’ ongoing quest to shed payroll this offseason. After missing out on Giancarlo Stanton, the club still needs reinforcements in the outfield and will have to fill a void at third base as well — all while steering clear of the luxury tax threshold. Right fielder Hunter Pence has reportedly been floated as a trade option, but has a full no-trade clause and will likely be harder to move. The Rangers, meanwhile, will add Moore to a starting rotation that already boasts left-handers Cole Hamels, Mike Minor and Martin Perez.